The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Reflex Sympathetic Dystrophy Syndrome Association of America
PO Box 502
Milford, CT 06460
The Reflex Sympathetic Dystrophy Syndrome Association of America (RSDSA) is a non-profit organization founded to promote greater public and professional awareness of complex regional pain syndrome (CRPS), formerly known as reflex sympathetic dystrophy syndrome (RSD) and support research into the causes and cure of complex regional pain symdrome/reflex sympathetic dystrophy (CRPS/RSD). The association's mission also includes the establishment and organization of support groups for affected individuals and their families; and promotion of awareness of reflex sympathetic dystrophy syndrome among healthcare professionals and the general public. Founded in 1984, the association provides a referral service to physicians, offers a pen pal service, and promotes patient advocacy. RSDA offers a variety of educational materials and services including an information packet, a quarterly newsletter, a statistical report on reflex sympathetic dystrophy syndrome derived from member questionnaires, reference articles, brochures, booklets, and videos. The association also provides educational in-service conferences for healthcare professionals and patients and has published clinical practice guidelines for the diagnosis, treatment, and management of RSD/CRPS.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.